A 35-year-old man presents to the emergency department with a 3-day history of increasing … — USMLE Step 2 CK

A $35$ -year-old man presents to the emergency department with a $3$ -day history of increasing fatigue, spontaneous gum bleeding, and a diffuse petechial rash. He has no significant past medical history and takes no medications. Vital signs are temperature $37.2^\circ\text{C}$ ( $99.0^\circ\text{F}$ ), heart rate $105/\text{min}$ , blood pressure $110/70\text{ mmHg}$ , and respiratory rate $18/\text{min}$ . Physical examination reveals pale conjunctivae, continuous oozing from the gingival margins, diffuse petechiae on the lower extremities, and large ecchymoses on the trunk. There is no hepatosplenomegaly or lymphadenopathy.

Laboratory results are as follows:

Laboratory Test	Result	Reference Range
Hemoglobin	$8.2\text{ g/dL}$	$13.5-17.5\text{ g/dL}$
Platelets	$18,000/\text{mm}^3$	$150,000-400,000/\text{mm}^3$
Leukocytes	$2,500/\text{mm}^3$	$4,500-11,000/\text{mm}^3$
Prothrombin time (PT)	$22\text{ sec}$	$11-15\text{ sec}$
Partial thromboplastin time (PTT)	$55\text{ sec}$	$25-40\text{ sec}$
Fibrinogen	$85\text{ mg/dL}$	$200-400\text{ mg/dL}$
D-dimer	$5,400\text{ ng/mL}$	$< 500\text{ ng/mL}$

A peripheral blood smear reveals numerous large, atypical mononuclear cells with abundant cytoplasm containing multiple primary granules and prominent needle-like cytoplasmic inclusions.

Which of the following is the most appropriate next step in management?

A
Bone marrow aspiration and flow cytometry
B
Initiation of broad-spectrum antibiotics
C
Plasma exchange therapy
D
Transfusion of fresh frozen plasma and cryoprecipitate only
Administration of all-trans retinoic acidAnswer

Answer

Administration of all-trans retinoic acid

This patient's presentation of pancytopenia, spontaneous mucosal bleeding, and a peripheral smear demonstrating numerous large mononuclear cells with prominent needle-like cytoplasmic inclusions (Auer rods) is highly suspicious for Acute Promyelocytic Leukemia (APL). APL, the M3 subtype of acute myeloid leukemia, is notorious for presenting with a life-threatening bleeding diathesis due to severe Disseminated Intravascular Coagulation (DIC). The leukemic promyelocytes contain primary granules rich in tissue factor and other procoagulants; when these cells turn over or are destroyed, the release of these factors triggers massive activation of the coagulation cascade. This is confirmed by the patient's markedly prolonged PT and PTT, hypofibrinogenemia, and elevated D-dimer. APL is a true oncologic emergency characterized by a high early mortality rate, primarily from intracranial or pulmonary hemorrhage. The most critical step in management is the immediate administration of all-trans retinoic acid (ATRA). ATRA overcomes the differentiation block caused by the characteristic

PML-RARA

fusion gene (a result of the

t(15;17)

translocation), allowing the malignant promyelocytes to mature into functional neutrophils. This differentiation rapidly halts the release of procoagulants and resolves the DIC. Crucially, ATRA must be initiated empirically the moment APL is suspected based on clinical features and peripheral smear findings; treatment must never be delayed to wait for confirmatory bone marrow biopsy or cytogenetic results.

Step-by-Step Solution

Analyze the patient's clinical presentation.

The patient exhibits severe, spontaneous mucosal and cutaneous bleeding (oozing gums, petechiae, ecchymoses) in an acute setting.

Bleeding diathesis narrows the differential to platelet disorders, coagulation factor deficiencies, or a consumptive process.

Interpret the laboratory and peripheral smear data.

Labs show pancytopenia, marked prolongation of PT and PTT, severe hypofibrinogenemia, and markedly elevated D-dimer. The smear shows atypical cells with needle-like inclusions (Auer rods).

The abnormal coagulation panel with low fibrinogen and high D-dimer confirms Disseminated Intravascular Coagulation (DIC). The smear findings are pathognomonic for Acute Promyelocytic Leukemia (APL).

Determine the pathogenesis of the current emergency.

The abnormal promyelocytes in APL are filled with primary granules that contain procoagulants (like tissue factor). The release of these contents heavily activates the coagulation cascade, driving the catastrophic DIC.

Understanding the driver of the DIC dictates that treating the underlying leukemia is the most effective way to stop the coagulopathy.

Select the most appropriate immediate intervention.

All-trans retinoic acid (ATRA) must be administered immediately.

ATRA forces the malignant promyelocytes to differentiate into mature neutrophils, abruptly halting the release of procoagulants. It should be given immediately upon clinical suspicion, prior to genetic confirmation of the

t(15;17)

translocation.

Key Concept

Acute Promyelocytic Leukemia (APL) is a medical emergency that frequently presents with severe Disseminated Intravascular Coagulation (DIC). Upon clinical or morphologic suspicion (e.g., Auer rods on smear), all-trans retinoic acid (ATRA) must be initiated immediately to prevent fatal hemorrhage.

Estimated Time:1m 30s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic